09.08.2022 14:45

Zacks.com featured highlights include Heska, Tandem Diabetes Care, Credit Suisse Group, Zalando SE and Las Vegas Sands

Folgen
Werbung
For Immediate ReleaseChicago, IL – August 9, 2022 – Stocks in this week’s article are Heska Corp. HSKA, Tandem Diabetes Care, Inc. TNDM, Credit Suisse Group CS, Zalando SE ZLNDY and Las Vegas Sands LVS.5 Toxic Stocks That May Prove Hazardous to Your PortfolioThere are always some stocks, which illusively scale lofty heights in a given time period. However, the good show doesn't last for these overblown toxic stocks as their current price is not justified by their fundamental strength.Toxic companies are usually characterized by huge debt loads and are vulnerable to external shocks. Accurately identifying such bloated stocks and getting rid of them at the right time can protect your portfolio.Overpricing of these toxic stocks can be attributed to either an irrational enthusiasm surrounding them or some serious fundamental drawbacks. If you own such bubble stocks for an inordinate period of time, you are bound to see a massive erosion of wealth.However, if you can precisely spot such toxic stocks, you may gain by resorting to an investing strategy called short selling. This strategy allows one to sell a stock first and then buy it when the price falls.While short selling excels in bear markets, it typically loses money in bull markets.So, just like identifying stocks with growth potential, pinpointing toxic stocks and offloading them at the right time is crucial to guard one's portfolio from big losses or make profits by short selling them. Heska Corp., Tandem Diabetes Care, Inc., Credit Suisse Group,Zalando SE and Las Vegas Sands are a few such toxic stocks.Here are five of the 20 stocks that made it through the screen:Colorado-based Heska sells advanced veterinary diagnostic and specialty products, primarily focused on canine and feline healthcare markets.  The company currently carries a Zacks Rank #5 (Strong Sell) and has a VGM Score of F. The Zacks Consensus Estimate for HSKA's 2022 bottom line implies a year-over-year decline of 10.6%. The consensus mark has moved south by 22 cents over the past seven days.Headquartered in California, Tandem Diabetes designs, develops and markets products for people with insulin-dependent diabetes. The company currently carries a Zacks Rank #5 and has a VGM Score of D. The Zacks Consensus Estimate for TNDM's 2022 bottom line implies a year-over-year plunge of 161.5%. The consensus mark has deteriorated from earnings of 35 cents a share to a loss of 16 cents over the past seven days.Based in Switzerland, Credit Suisse offers investment products, private banking and financial advisory services, as well as insurance and pension solutions. The company currently carries a Zacks Rank #5 and has a VGM Score of C. The Zacks Consensus Estimate for CS's 2022 bottom line implies a year-over-year slump of 666.7%. The consensus mark has deteriorated from earnings of 11 cents a share to a loss of 69 cents over the past 30 days.Headquartered in Berlin, Zalando is an online fashion retailer offering clothing, sports products, shoes, bags and other accessories for men, women and children. The company currently carries a Zacks Rank #4 (Sell) and has a VGM Score of F. The Zacks Consensus Estimate for ZLNDY's 2022 earnings implies a year-over-year decline of 73%. The consensus mark has moved south by 25 cents in the past 60 days.Las Vegas Sands is an international developer of multi-use integrated resorts, primarily operating in the United States and Asia. Based in Las Vegas, LVS carries a Zacks Rank #4 and has a VGM Score of F. The Zacks Consensus Estimate for Las Vegas' 2022 bottom line is pegged at a loss of $1.10 a share. The consensus mark of loss per share has widened from 89 cents to $1.10 in the past 30 days.Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial to the Research Wizard today.For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/1965159/5-toxic-stocks-that-may-prove-hazardous-for-your-portfolioDisclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.About Screen of the WeekZacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.Strong Stocks that Should Be in the NewsMany are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.Follow us on Twitter:  https://www.twitter.com/zacksresearchJoin us on Facebook:  https://www.facebook.com/ZacksInvestmentResearchZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.Want to Know the #1 Semiconductor Stock for 2022?Few people know how promising the semiconductor market is. Over the last couple of years, disruptions to the supply chain have caused shortages in several industries. The absence of one single semiconductor can stop all operations in certain industries.This year, companies that create and produce this essential material will have incredible pricing power. For a limited time, Zacks is revealing the top semiconductor stock for 2022. You'll find it in our new Special Report, One Semiconductor Stock Stands to Gain the Most.Today, it's yours free with no obligation.>>Give me access to my free special report.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Credit Suisse Group (CS): Free Stock Analysis Report Las Vegas Sands Corp. (LVS): Free Stock Analysis Report Heska Corporation (HSKA): Free Stock Analysis Report Tandem Diabetes Care, Inc. (TNDM): Free Stock Analysis Report Zalando (ZLNDY): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Weiter zum vollständigen Artikel bei "Zacks"
Ausgewählte Hebelprodukte auf Credit Suisse (CS)
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Credit Suisse (CS)
Long
Short
Hebel wählen:
5x
10x
Name
Hebel
KO
Emittent
Quelle: Zacks

Nachrichten zu Zalando

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Zalando

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
29.09.2022Zalando BuyHauck & Aufhäuser Privatbankiers KGaA
23.09.2022Zalando OutperformRBC Capital Markets
22.09.2022Zalando HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
22.09.2022Zalando BuyGoldman Sachs Group Inc.
21.09.2022Zalando OutperformCredit Suisse Group
29.09.2022Zalando BuyHauck & Aufhäuser Privatbankiers KGaA
23.09.2022Zalando OutperformRBC Capital Markets
22.09.2022Zalando BuyGoldman Sachs Group Inc.
21.09.2022Zalando OutperformCredit Suisse Group
15.09.2022Zalando BuyGoldman Sachs Group Inc.
22.09.2022Zalando HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
08.09.2022Zalando HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
08.09.2022Zalando HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
07.09.2022Zalando NeutralJP Morgan Chase & Co.
07.09.2022Zalando Equal WeightBarclays Capital
27.06.2022Zalando HoldHSBC
24.06.2022Zalando UnderperformMerrill Lynch & Co., Inc.
27.04.2022Zalando UnderperformMerrill Lynch & Co., Inc.
28.01.2021Zalando VerkaufenDZ BANK
23.11.2020Zalando SellJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Zalando nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Werbung
Werbung
Werbung
Neue Funktionen als Erstes nutzen
Sie nutzen finanzen.net regelmäßig? Dann nutzen Sie jetzt neue Funktionen als Erstes!
Hier informieren!
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

DAX stabil erwartet -- Asiens Börsen uneins -- Nike-Gewinn leidet unter Logistik-Kosten und starkem Dollar -- Neue Führungsspitze bei Fresenius und FMC startet Samstag

Strompreise: EU-Staaten wollen Verbraucher entlasten. BVB-Trainer Terzic setzt große Hoffnungen auf neuen Stürmer Anthony Modeste. Zuckerberg will bei Meta sparen. Luc Rémont soll französischen Energiekonzern EDF leiten. Heike Eckert bleibt weitere fünf Jahre im Vorstand der Deutschen Börse.

Umfrage

Sollte Deutschland Kampfpanzer und weitere schwere Waffen an die Ukraine zu liefern

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln